These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 7458992)
1. Effect of probucol on plasma lipids and lipoproteins in type IIb hyperlipoproteinemia. Hunninghake DB; Bell C; Olson L Atherosclerosis; 1980 Nov; 37(3):469-74. PubMed ID: 7458992 [TBL] [Abstract][Full Text] [Related]
2. [Clinical research on the hypolipidemic action of a probucol preparation]. Naumova R; Kerekovska M; Goranov I; Balabanski L Vutr Boles; 1986; 25(2):73-7. PubMed ID: 3716382 [TBL] [Abstract][Full Text] [Related]
3. Effect of probucol treatment on lipoprotein cholesterol and drug levels in blood and lipoproteins in familial hypercholesterolemia. Fellin R; Gasparotto A; Valerio G; Baiocchi MR; Padrini R; Lamon S; Vitale E; Baggio G; Crepaldi G Atherosclerosis; 1986 Jan; 59(1):47-56. PubMed ID: 3081013 [TBL] [Abstract][Full Text] [Related]
4. The hypolipidemic action of probucol: a study of its effects on high and low density lipoproteins. Atmeh RF; Stewart JM; Boag DE; Packard CJ; Lorimer AR; Shepherd J J Lipid Res; 1983 May; 24(5):588-95. PubMed ID: 6875383 [TBL] [Abstract][Full Text] [Related]
5. Effects of probucol on plasma cholesterol, high and low density lipoprotein cholesterol, and apolipoproteins A1 and A2 in adults with primary familial hypercholesterolemia. Mellies MJ; Gartside PS; Glatfelter L; Vink P; Guy G; Schonfeld G; Glueck CJ Metabolism; 1980 Oct; 29(10):956-64. PubMed ID: 6999291 [No Abstract] [Full Text] [Related]
6. [Effects of medium-term probucol treatment on plasma lipids and lipoproteins. 16 cases of type IIa and IIb hyperlipoproteinaemia (author's transl)]. Rouffy J; Chanu B; Bakir R; Goy-Loepper J; Saya C Nouv Presse Med; 1980 Oct; 9(40):3014-7. PubMed ID: 7443443 [TBL] [Abstract][Full Text] [Related]
7. The effects of probucol on plasma lipoproteins in polygenic and familial hypercholesterolaemia. Cortese C; Marenah CB; Miller NE; Lewis B Atherosclerosis; 1982 Sep; 44(3):319-25. PubMed ID: 7150396 [TBL] [Abstract][Full Text] [Related]
8. Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride. Witztum JL; Simmons D; Steinberg D; Beltz WF; Weinreb R; Young SG; Lester P; Kelly N; Juliano J Circulation; 1989 Jan; 79(1):16-28. PubMed ID: 2642754 [TBL] [Abstract][Full Text] [Related]
9. Decrease of plasma large, light LDL (LDL1), HDL2 and HDL3 levels with concomitant increase of cholesteryl ester transfer protein (CETP) activity by probucol in type II hyperlipoproteinemia. Homma Y; Kobayashi T; Yamaguchi H; Sakane H; Ozawa H; Matsuda M; Mikami Y; Mikami Y; Nakamura H Artery; 1993; 20(1):1-18. PubMed ID: 8447724 [TBL] [Abstract][Full Text] [Related]
10. A comparison of cholestyramine and probucol in the treatment of familial hypercholesterolaemia. Jones DB; Simpson HC; Slaughter P; Lousley S; Carter RD; Cobbe SM; Mann JI Atherosclerosis; 1984 Oct; 53(1):1-7. PubMed ID: 6388586 [TBL] [Abstract][Full Text] [Related]
11. The hypolipidemic action of probucol. Drug transport and lipoprotein composition in type IIa hyperlipoproteinemia. Dachet C; Jacotot B; Buxtorf JC Atherosclerosis; 1985 Dec; 58(1-3):261-8. PubMed ID: 4091882 [TBL] [Abstract][Full Text] [Related]
12. Probucol in hypercholesterolemia. A double blind study. Riesen WF; Keller M; Mordasini R Atherosclerosis; 1980 Jun; 36(2):201-7. PubMed ID: 7406949 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms of HDL reduction after probucol. Changes in HDL subfractions and increased reverse cholesteryl ester transfer. Franceschini G; Sirtori M; Vaccarino V; Gianfranceschi G; Rezzonico L; Chiesa G; Sirtori CR Arteriosclerosis; 1989; 9(4):462-9. PubMed ID: 2751476 [TBL] [Abstract][Full Text] [Related]
14. Modifications in the chemical composition and thermometric behavior of LDL and HDL by probucol in type IIa hyperlipoproteinemia. Dachet C; Motta C; Neufcour D; Jacotot B Adv Exp Med Biol; 1988; 243():179-84. PubMed ID: 3223415 [No Abstract] [Full Text] [Related]
15. Effects of probucol on the composition and in vitro catabolism of LDL in type IIa hypercholesterolemia. Baudet MF; Esteva O; Dachet C; Jacotot B Atherosclerosis; 1986 Oct; 62(1):65-71. PubMed ID: 3778575 [TBL] [Abstract][Full Text] [Related]
16. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia. Yovos JG; Patel ST; Falko JM; Newman HA; Hill DS J Clin Endocrinol Metab; 1982 Jun; 54(6):1210-5. PubMed ID: 7076797 [TBL] [Abstract][Full Text] [Related]
17. Selective reduction of cholesterol in HDL2 fraction by probucol in familial hypercholesterolemia and hyperHDL2 cholesterolemia with abnormal cholesteryl ester transfer. Matsuzawa Y; Yamashita S; Funahashi T; Yamamoto A; Tarui S Am J Cardiol; 1988 Jul; 62(3):66B-72B. PubMed ID: 3394656 [TBL] [Abstract][Full Text] [Related]
18. Changes in high-density lipoprotein subfraction distribution and increased cholesteryl ester transfer after probucol. Sirtori CR; Sirtori M; Calabresi L; Franceschini G Am J Cardiol; 1988 Jul; 62(3):73B-76B. PubMed ID: 3293417 [TBL] [Abstract][Full Text] [Related]
19. Effect of colestipol and clofibrate, singly and in combination, on plasma lipid and lipoproteins in type IIb hyperlipoproteinemia. Hunninghake DB; Bell C; Olson L Metabolism; 1981 Jun; 30(6):610-5. PubMed ID: 7231198 [TBL] [Abstract][Full Text] [Related]
20. Effect of colestipol and clofibrate on plasma lipid and lipoproteins in type IIa hyperlipoproteinemia. Hunninghake DB; Probstfield JL; Crow LO; Isaacson SO Metabolism; 1981 Jun; 30(6):605-9. PubMed ID: 7231197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]